Compare CRCT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | EVO |
|---|---|---|
| Founded | 1969 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2021 | 2021 |
| Metric | CRCT | EVO |
|---|---|---|
| Price | $5.08 | $3.23 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.18 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 602.3K | 92.1K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | ★ 18.76% | N/A |
| EPS Growth | ★ 27.98 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | $714,492,000.00 | ★ $887,396,457.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.80 |
| P/E Ratio | $13.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $2.84 |
| 52 Week High | $7.33 | $5.10 |
| Indicator | CRCT | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 46.03 |
| Support Level | $4.65 | $3.08 |
| Resistance Level | $4.90 | $3.24 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 100.00 | 72.83 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.